Ayurcann Holdings Corp. (AYUR.CN)
CAD 0.03
(-16.67%)
CAD 0.03
(-16.67%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 14.31 Million CAD | 42.65% |
| 2022 | 10.03 Million CAD | 320.17% |
| 2021 | 2.38 Million CAD | 23.92% |
| 2020 | 1.92 Million CAD | 10449.9% |
| 2019 | 18.27 Thousand CAD | -2.19% |
| 2018 | 18.68 Thousand CAD | -50.32% |
| 2017 | 37.6 Thousand CAD | 97.74% |
| 2016 | 19.01 Thousand CAD | -14.8% |
| 2015 | 22.32 Thousand CAD | -6.95% |
| 2014 | 23.98 Thousand CAD | -27.92% |
| 2013 | 33.27 Thousand CAD | -80.46% |
| 2012 | 170.29 Thousand CAD | 443.83% |
| 2011 | 31.31 Thousand CAD | -30.7% |
| 2010 | 45.18 Thousand CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q1 | 11.82 Million CAD | 17.76% |
| 2023 Q3 | 15.15 Million CAD | 6.29% |
| 2023 Q2 | 14.25 Million CAD | 20.62% |
| 2023 Q4 | 14.31 Million CAD | -5.52% |
| 2022 FY | 10.03 Million CAD | 320.17% |
| 2022 Q3 | 4.83 Million CAD | 28.59% |
| 2022 Q4 | 10.03 Million CAD | 107.65% |
| 2022 Q2 | 3.75 Million CAD | 24.99% |
| 2022 Q1 | 3 Million CAD | 25.9% |
| 2021 Q3 | 2.13 Million CAD | -28.99% |
| 2021 Q1 | 2.06 Million CAD | 7.05% |
| 2021 FY | 2.38 Million CAD | 23.92% |
| 2021 Q2 | 3 Million CAD | 45.42% |
| 2021 Q4 | 2.38 Million CAD | 12.11% |
| 2020 Q1 | 18.27 Thousand CAD | 328.14% |
| 2020 FY | 1.92 Million CAD | 10449.9% |
| 2020 Q4 | 1.92 Million CAD | 8.46% |
| 2020 Q3 | 1.77 Million CAD | 33787.84% |
| 2020 Q2 | 5245.00 CAD | -71.3% |
| 2019 Q2 | 16.02 Thousand CAD | -14.23% |
| 2019 Q3 | 14.04 Thousand CAD | -12.38% |
| 2019 FY | 18.27 Thousand CAD | -2.19% |
| 2019 Q4 | 4268.00 CAD | -69.6% |
| 2019 Q1 | 18.68 Thousand CAD | 846.45% |
| 2018 Q3 | 8257.00 CAD | -24.81% |
| 2018 FY | 18.68 Thousand CAD | -50.32% |
| 2018 Q4 | 1974.00 CAD | -76.09% |
| 2018 Q2 | 10.98 Thousand CAD | -70.8% |
| 2018 Q1 | 37.6 Thousand CAD | 645.77% |
| 2017 Q3 | 5745.00 CAD | -51.65% |
| 2017 Q2 | 11.88 Thousand CAD | -37.52% |
| 2017 Q1 | 19.01 Thousand CAD | 319.57% |
| 2017 FY | 37.6 Thousand CAD | 97.74% |
| 2017 Q4 | 5043.00 CAD | -12.22% |
| 2016 Q2 | 14.18 Thousand CAD | -36.44% |
| 2016 Q1 | 22.32 Thousand CAD | 876.47% |
| 2016 FY | 19.01 Thousand CAD | -14.8% |
| 2016 Q3 | 5829.00 CAD | -58.92% |
| 2016 Q4 | 4533.00 CAD | -22.23% |
| 2015 Q3 | 2393.00 CAD | -83.06% |
| 2015 Q4 | 2286.00 CAD | -4.47% |
| 2015 Q2 | 14.13 Thousand CAD | -41.1% |
| 2015 Q1 | 23.98 Thousand CAD | 1085.76% |
| 2015 FY | 22.32 Thousand CAD | -6.95% |
| 2014 FY | 23.98 Thousand CAD | -27.92% |
| 2014 Q4 | 2023.00 CAD | -90.28% |
| 2014 Q3 | 20.8 Thousand CAD | -20.24% |
| 2014 Q2 | 26.08 Thousand CAD | -21.61% |
| 2014 Q1 | 33.27 Thousand CAD | -88.62% |
| 2013 Q4 | 292.54 Thousand CAD | -0.49% |
| 2013 FY | 33.27 Thousand CAD | -80.46% |
| 2013 Q2 | 155.58 Thousand CAD | -8.64% |
| 2013 Q3 | 293.98 Thousand CAD | 88.96% |
| 2013 Q1 | 170.29 Thousand CAD | -43.05% |
| 2012 FY | 170.29 Thousand CAD | 443.83% |
| 2012 Q1 | 607.6 Thousand CAD | -48.52% |
| 2012 Q2 | 458.1 Thousand CAD | -24.6% |
| 2012 Q3 | 375.44 Thousand CAD | -18.05% |
| 2012 Q4 | 299.02 Thousand CAD | -20.35% |
| 2011 FY | 31.31 Thousand CAD | -30.7% |
| 2011 Q2 | 31.31 Thousand CAD | 340.55% |
| 2011 Q1 | 7108.00 CAD | -46.85% |
| 2011 Q4 | 1.18 Million CAD | 2197.05% |
| 2011 Q3 | 51.37 Thousand CAD | 64.08% |
| 2010 Q3 | 4766.00 CAD | 0.0% |
| 2010 FY | 45.18 Thousand CAD | 0.0% |
| 2010 Q4 | 13.37 Thousand CAD | 180.61% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aion Therapeutic Inc. | 2.93 Million CAD | -387.622% |
| Blueberries Medical Corp. | 470.72 Thousand CAD | -2941.917% |
| The BC Bud Corporation | 626 Thousand CAD | -2187.366% |
| BioNxt Solutions Inc. | 6.55 Million CAD | -118.603% |
| CordovaCann Corp. | 11.29 Million CAD | -26.819% |
| Christina Lake Cannabis Corp. | 8.5 Million CAD | -68.439% |
| Captor Capital Corp. | 28.76 Million CAD | 50.22% |
| City View Green Holdings Inc. | 3.73 Million CAD | -283.582% |
| 1CM Inc. | 9.42 Million CAD | -51.947% |
| Global Hemp Group Inc. | 5.82 Million CAD | -145.814% |
| Greenway Greenhouse Cannabis Corporation | 21.17 Million CAD | 32.375% |
| IM Cannabis Corp. | 35.11 Million CAD | 59.22% |
| Lobe Sciences Ltd. | 2.45 Million CAD | -482.164% |
| Maple Leaf Green World Inc. | 10.08 Million CAD | -42.04% |
| Mountain Valley MD Holdings Inc. | 258 Thousand CAD | -5450.001% |
| Nextleaf Solutions Ltd. | 4.4 Million CAD | -225.184% |
| Ovation Science Inc. | 728.99 Thousand CAD | -1864.219% |
| Pharmadrug Inc. | 2.92 Million CAD | -389.46% |
| Captiva Verde Wellness Corp. | 2.08 Million CAD | -585.462% |
| RAMM Pharma Corp. | 2.83 Million CAD | -404.988% |
| RIV Capital Inc. | 275.63 Million CAD | 94.805% |
| Revive Therapeutics Ltd. | 3.4 Million CAD | -320.66% |
| Red White & Bloom Brands Inc. | 364.63 Million CAD | 96.073% |
| SLANG Worldwide Inc. | 37.58 Million CAD | 61.9% |
| 1933 Industries Inc. | 23.28 Million CAD | 38.5% |
| Red Light Holland Corp. | 3.82 Million CAD | -274.68% |
| Top Strike Resources Corp. | 20.99 Million CAD | 31.795% |
| Xebra Brands Ltd. | 789.95 Thousand CAD | -1712.635% |
| Adastra Holdings Ltd. | 17.65 Million CAD | 18.908% |